The efficacy of licensed rotavirus vaccines has only been shown against certain rotavirus
group A (RV‐A) types. It is critical to understand the burden of rotavirus gastroenteritis …

Background The safety and efficacy of an attenuated G1P [8] human rotavirus (HRV) vaccine
were tested in a randomized, double-blind, phase 3 trial. Methods We studied 63,225 …

Background: A substantial number of surveillance studies have documented rotavirus
prevalence among children admitted for dehydrating diarrhea. We sought to establish global …

Objective To evaluate the effectiveness of a monovalent rotavirus vaccine against severe
rotavirus disease and to assess its impact on diarrhoea in children aged less than 2 years …

OBJECTIVE: To study the epidemiology of rotavirus and estimate rotavirus-associated
morbidity and mortality in children< 5 years of age in Brazil in 2004 before introducing the …

Background: A recent postlicensure study from El Salvador showed that the monovalent
rotavirus vaccine conferred 76% protection against rotavirus hospitalizations. We further …

Background: In March 2006, rotavirus vaccine (Rotarix, RV1) was introduced into the
Panamanian national immunization program. We assessed the effect of vaccine on diarrhea …

OBJECTIVES: To estimate the costs, benefits and cost-effectiveness of vaccination for
rotavirus gastroenteritis in eight Latin American and Caribbean countries: Argentina, Brazil …

OBJECTIVE: To estimate the health and economic burden of rotavirus gastroenteritis in
hospital and outpatient settings in eight Latin American and Caribbean countries (Argentina …

Rotavirus is a leading cause of acute diarrhea in children worldwide. Costa Rica recently
started universal rotavirus vaccinations for infants with a two-dose schedule in February …